AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2012
May 3, 2012
31261_dirs_2012-05-03_730106f6-4980-4b61-a54b-e9036937b439.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADMA BIOLOGICS, INC. (NONE)
CIK: 0001368514
Period of Report: 2012-05-01
Reporting Person: LENZ BRIAN (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-01 | Options to purchase | $9.60 | A | 66292 | Acquired | 2022-05-01 | Common Stock (66292) | Direct |
Footnotes
F1: These options vest over four years with 25% vesting on May 1, 2013, and the remaining 75% vesting in equal monthly installments over the next 36 months.
More from ADMA BIOLOGICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3